Ibaraki, Japan

Katsuhiko Masuda

This inventor holds 1 USPTO granted patent. Top assignee: Mitsubishi Chemical Corporation. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Katsuhiko Masuda. Retrieved from https://idiyas.com/inventor/katsuhiko-masuda-c03kkcbv

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Katsuhiko Masuda

Introduction

Katsuhiko Masuda is a notable inventor based in Ibaraki, Japan. He has made significant contributions to the field of pharmaceuticals through his innovative work on crystal forms of specific compounds. His research has implications for drug stability and preparation.

Latest Patents

Masuda holds a patent for the invention titled "Crystals of 5-[{6-(2-fluorobenzyl)oxy-2-naphthyl}methyl]-2,4-thiazolidinedione." This invention relates to a type A crystal characterized by distinct absorption peaks in a powder X-ray diffraction pattern. The crystal exhibits excellent stability and offers advantages in handling, storage, and pharmaceutical preparation. Additionally, the invention encompasses type B, C, and D crystals of the same compound.

Career Highlights

Katsuhiko Masuda is associated with Mitsubishi Chemical Corporation, where he has been able to apply his expertise in the development of pharmaceutical compounds. His work has contributed to advancements in the field, particularly in the stability and efficacy of drug formulations.

Collaborations

Masuda has collaborated with notable colleagues, including Takayuki Oe and Hiroaki Ueno. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Katsuhiko Masuda's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to advancing drug stability and preparation methods. His work continues to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…